Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Diabetes

  Free Subscription


30.09.2019

1 Am J Cardiol
1 Am J Ophthalmol
1 Circulation
5 Diabet Med
3 Diabetes
15 Diabetes Care
2 Invest Ophthalmol Vis Sci
1 J Clin Endocrinol Metab
2 J Clin Invest
3 JAMA
3 Kidney Int
2 Lancet
2 Lancet Diabetes Endocrinol
2 N Engl J Med
1 Nature
1 Ophthalmol Retina
3 PLoS One


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Am J Cardiol

  1. PEPE M, Sardella G, Stefanini GG, Corcione N, et al
    Impact of Insulin-Treated and Noninsulin-Treated Diabetes Mellitus in All-Comer Patients Undergoing Percutaneous Coronary Interventions With Polymer-Free Biolimus-Eluting Stent (from the RUDI-FREE Registry).
    Am J Cardiol. 2019 Aug 23. pii: S0002-9149(19)30956.
    PubMed     Text format     Abstract available


    Am J Ophthalmol

  2. HAFNER J, Zadrazil M, Grisold A, Ricken G, et al
    Retinal and corneal neurodegeneration and its association to systemic signs of peripheral neuropathy in type 2 diabetes.
    Am J Ophthalmol. 2019 Sep 19. pii: S0002-9394(19)30468.
    PubMed     Text format     Abstract available


    Circulation

  3. FUDIM M, White J, Pagidipati NJ, Lokhnygina Y, et al
    Effect of Once-Weekly Exenatide in Patients With Type 2 Diabetes With and Without Heart Failure and Heart Failure-Related Outcomes: Insights From the EXSCEL Trial.
    Circulation. 2019 Sep 23. doi: 10.1161/CIRCULATIONAHA.119.041659.
    PubMed     Text format     Abstract available


    Diabet Med

  4. SHARMA M, Kumar M, Dutta D
    Hydroxychloroquine in diabetes and dyslipidaemia: primum non nocere.
    Diabet Med. 2019 Sep 26. doi: 10.1111/dme.14144.
    PubMed     Text format     Abstract available

  5. KOMORITA Y, Iwase M, Fujii H, Ohkuma T, et al
    Both hypo- and hyperglycaemia are associated with increased fracture risk in Japanese people with type 2 diabetes: Fukuoka Diabetes Registry.
    Diabet Med. 2019 Sep 25. doi: 10.1111/dme.14142.
    PubMed     Text format     Abstract available

  6. WOOD SJ, Magliano DJ, Bell JS, Shaw JE, et al
    Pharmacological treatment initiation for type 2 diabetes in Australia: are the guidelines being followed?
    Diabet Med. 2019 Sep 26. doi: 10.1111/dme.14149.
    PubMed     Text format     Abstract available

  7. GETTINGS JM, Willi SM, Forth E, Hawkes CP, et al
    Integrating the Patient Health Questionnaire-2 depression screening tool into the paediatric diabetes clinic.
    Diabet Med. 2019 Sep 26. doi: 10.1111/dme.14146.
    PubMed     Text format     Abstract available

  8. PICKWELL K, Geerts M, van Moorsel D, Hilkman D, et al
    Regional differences in cell-mediated immunity in people with diabetic peripheral neuropathy.
    Diabet Med. 2019 Sep 26. doi: 10.1111/dme.14143.
    PubMed     Text format     Abstract available


    Diabetes

  9. GHIASI SM, Dahlby T, Hede Andersen C, Haataja L, et al
    Endoplasmic Reticulum Chaperone Glucose-Regulated Protein 94 Is Essential for Proinsulin Handling.
    Diabetes. 2019;68:747-760.
    PubMed     Text format     Abstract available

  10. SHARMA S, Pettus J, Gottschalk M, Abe B, et al
    Single-Cell Analysis of CD4 T Cells in Type 1 Diabetes: From Mouse to Man, How to Perform Mechanistic Studies.
    Diabetes. 2019;68:1886-1891.
    PubMed     Text format     Abstract available


  11. In This Issue of Diabetes.
    Diabetes. 2019;68:1871-1872.
    PubMed     Text format    


    Diabetes Care

  12. PETTUS JH, Zhou FL, Shepherd L, Preblick R, et al
    Incidences of Severe Hypoglycemia and Diabetic Ketoacidosis and Prevalence of Microvascular Complications Stratified by Age and Glycemic Control in U.S. Adult Patients With Type 1 Diabetes: A Real-World Study.
    Diabetes Care. 2019 Sep 23. pii: dc19-0830. doi: 10.2337/dc19-0830.
    PubMed     Text format     Abstract available

  13. CATARGI B, Darier R, Montaudon M, Beauvieux MC, et al
    Response to Comment on Gerbaud et al. Glycemic Variability Is a Powerful Independent Predictive Factor of Midterm Major Adverse Cardiac Events in Patients With Diabetes With Acute Coronary Syndrome. Diabetes Care 2019;42:674-681.
    Diabetes Care. 2019;42:e170-e171.
    PubMed     Text format    

  14. YANG Y, Hu Y
    Comment on Gerbaud et al. Glycemic Variability Is a Powerful Independent Predictive Factor of Midterm Major Adverse Cardiac Events in Patients With Diabetes With Acute Coronary Syndrome. Diabetes Care 2019;42:674-681.
    Diabetes Care. 2019;42:e168-e169.
    PubMed     Text format    

  15. DABELEA D, Hamman RF
    Elevated Cardiometabolic Risk Profile Among Young Adults With Diabetes: Need for Action.
    Diabetes Care. 2019;42:1845-1846.
    PubMed     Text format    

  16. MACISAAC RJ, Ekinci EI
    Progression of Diabetic Kidney Disease in the Absence of Albuminuria.
    Diabetes Care. 2019;42:1842-1844.
    PubMed     Text format    


  17. In This Issue of Diabetes Care.
    Diabetes Care. 2019;42:1839-1840.
    PubMed     Text format    

  18. KAHL S, Gancheva S, Strassburger K, Herder C, et al
    Empagliflozin Effectively Lowers Liver Fat Content in Well-Controlled Type 2 Diabetes: A Randomized, Double-Blind, Phase 4, Placebo-Controlled Trial.
    Diabetes Care. 2019 Sep 20. pii: dc19-0641. doi: 10.2337/dc19-0641.
    PubMed     Text format     Abstract available

  19. DIVAKARAN S, Singh A, Biery D, Yang J, et al
    Diabetes Is Associated With Worse Long-term Outcomes in Young Adults After Myocardial Infarction: The Partners YOUNG-MI Registry.
    Diabetes Care. 2019 Sep 23. pii: dc19-0998. doi: 10.2337/dc19-0998.
    PubMed     Text format     Abstract available

  20. JAKUBOWICZ D, Landau Z, Tsameret S, Wainstein J, et al
    Reduction in Glycated Hemoglobin and Daily Insulin Dose Alongside Circadian Clock Upregulation in Patients With Type 2 Diabetes Consuming a Three-Meal Diet: A Randomized Clinical Trial.
    Diabetes Care. 2019 Sep 23. pii: dc19-1142. doi: 10.2337/dc19-1142.
    PubMed     Text format     Abstract available

  21. AGRAWAL L, Azad N, Bahn GD, Reaven PD, et al
    Intensive Glycemic Control Improves Long-term Renal Outcomes in Type 2 Diabetes in the Veterans Affairs Diabetes Trial (VADT).
    Diabetes Care. 2019 Sep 23. pii: dc19-0891. doi: 10.2337/dc19-0891.
    PubMed     Text format    

  22. LEBLANC ES, Pratley RE, Dawson-Hughes B, Staten MA, et al
    Erratum. Baseline Characteristics of the Vitamin D and Type 2 Diabetes (D2d) Study: A Contemporary Prediabetes Cohort That Will Inform Diabetes Prevention Efforts. Diabetes Care 2018;41:1590-1599.
    Diabetes Care. 2019 Sep 23. pii: dc19-er12. doi: 10.2337.
    PubMed     Text format    

  23. YUAN S, Jiang X, Michaelsson K, Larsson SC, et al
    Genetic Prediction of Serum 25-Hydroxyvitamin D, Calcium, and Parathyroid Hormone Levels in Relation to Development of Type 2 Diabetes: A Mendelian Randomization Study.
    Diabetes Care. 2019 Sep 23. pii: dc19-1247. doi: 10.2337/dc19-1247.
    PubMed     Text format     Abstract available

  24. MYERSON R, Romley J, Chiou T, Peters AL, et al
    The Affordable Care Act and Health Insurance Coverage Among People With Diagnosed and Undiagnosed Diabetes: Data From the National Health and Nutrition Examination Survey.
    Diabetes Care. 2019 Sep 23. pii: dc19-0081. doi: 10.2337/dc19-0081.
    PubMed     Text format    

  25. QUAST T, Andel R, Sadhu AR
    Long-term Effects of Disasters on Seniors With Diabetes: Evidence From Hurricanes Katrina and Rita.
    Diabetes Care. 2019 Sep 23. pii: dc19-0567. doi: 10.2337/dc19-0567.
    PubMed     Text format     Abstract available

  26. KLONOFF D, Bode B, Cohen N, Penn M, et al
    Divergent Hypoglycemic Effects of Hepatic-Directed Prandial Insulin: A Six-Month Phase 2b Study in Type 1 Diabetes.
    Diabetes Care. 2019 Sep 24. pii: dc19-0152. doi: 10.2337/dc19-0152.
    PubMed     Text format     Abstract available


    Invest Ophthalmol Vis Sci

  27. LIU E, Kaidonis G, McComish BJ, Gillies MC, et al
    MicroRNA-Related Genetic Variants Are Associated With Diabetic Retinopathy in Type 1 Diabetes Mellitus.
    Invest Ophthalmol Vis Sci. 2019;60:3937-3942.
    PubMed     Text format     Abstract available

  28. MOHAMMAD G, Radhakrishnan R, Kowluru RA
    Epigenetic Modifications Compromise Mitochondrial DNA Quality Control in the Development of Diabetic Retinopathy.
    Invest Ophthalmol Vis Sci. 2019;60:3943-3951.
    PubMed     Text format     Abstract available


    J Clin Endocrinol Metab

  29. YEN FS, Wang HC, Pan CW, Wei JC, et al
    Pioglitazone Exposure Reduced the Risk of All-Cause Mortality in Insulin-Treated Patients with Type 2 Diabetes Mellitus.
    J Clin Endocrinol Metab. 2019 Sep 23. pii: 5572576. doi: 10.1210.
    PubMed     Text format     Abstract available


    J Clin Invest

  30. MEYER MM
    Trials and tribulations of diabetes: a patient's perspective.
    J Clin Invest. 2019 Sep 23. pii: 132144. doi: 10.1172/JCI132144.
    PubMed     Text format    

  31. SODHI A, Ma T, Menon D, Deshpande M, et al
    Angiopoietin-like 4 binds neuropilins and cooperates with VEGF to induce diabetic macular edema.
    J Clin Invest. 2019 Sep 23. pii: 120879. doi: 10.1172/JCI120879.
    PubMed     Text format     Abstract available


    JAMA

  32. MCCOY RG, Rodriguez-Gutierrez R
    Measuring the Quality of Diabetes Care-Reply.
    JAMA. 2019;322:1212-1213.
    PubMed     Text format    

  33. GIUGLIANO D, Maiorino MI, Esposito K
    Measuring the Quality of Diabetes Care.
    JAMA. 2019;322:1212.
    PubMed     Text format    

  34. SHAH NS, Lloyd-Jones DM, O'Flaherty M, Capewell S, et al
    Trends in Cardiometabolic Mortality in the United States, 1999-2017.
    JAMA. 2019;322:780-782.
    PubMed     Text format    


    Kidney Int

  35. MARQUEZ A, Batlle D
    Angiotensin-(1-7) for diabetic kidney disease: better than an angiotensin-converting enzyme inhibitor alone?
    Kidney Int. 2019;96:815-817.
    PubMed     Text format     Abstract available

  36. ITO M, Nangaku M
    Increased albuminuria in bardoxolone methyl-treated type 2 diabetes patients: mere reflection of eGFR improvement?
    Kidney Int. 2019;96:823-825.
    PubMed     Text format     Abstract available

  37. NISHI H, Nangaku M
    Podocyte lipotoxicity in diabetic kidney disease.
    Kidney Int. 2019;96:809-812.
    PubMed     Text format    


    Lancet

  38. MATTHEWS DR, Paldanius PM, Proot P, Chiang Y, et al
    Glycaemic durability of an early combination therapy with vildagliptin and metformin versus sequential metformin monotherapy in newly diagnosed type 2 diabetes (VERIFY): a 5-year, multicentre, randomised, double-blind trial.
    Lancet. 2019 Sep 17. pii: S0140-6736(19)32131.
    PubMed     Text format     Abstract available

  39. MOSENZON O, Leibowitz G
    VERIFY the role of initial combination therapy in patients with type 2 diabetes.
    Lancet. 2019 Sep 17. pii: S0140-6736(19)32165.
    PubMed     Text format    


    Lancet Diabetes Endocrinol

  40. SCHEEN AJ
    SGLT2 inhibitor or GLP-1 receptor agonist in type 2 diabetes?
    Lancet Diabetes Endocrinol. 2019 Sep 17. pii: S2213-8587(19)30310.
    PubMed     Text format    

  41. LINGVAY I, Catarig AM, Frias JP, Kumar H, et al
    Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial.
    Lancet Diabetes Endocrinol. 2019 Sep 17. pii: S2213-8587(19)30311.
    PubMed     Text format     Abstract available


    N Engl J Med

  42. CERIELLO A, Nicolucci A
    Intensive Glucose Control and Type 2 Diabetes - 15 Years On.
    N Engl J Med. 2019;381:1292-1293.
    PubMed     Text format    

  43. REAVEN PD, Hayward RA, Zhou J
    Intensive Glucose Control and Type 2 Diabetes - 15 Years On. Reply.
    N Engl J Med. 2019;381:1293.
    PubMed     Text format    


    Nature

  44. FINDEISEN M, Allen TL, Henstridge DC, Kammoun H, et al
    Treatment of type 2 diabetes with the designer cytokine IC7Fc.
    Nature. 2019 Sep 25. pii: 10.1038/s41586-019-1601.
    PubMed     Text format     Abstract available


    Ophthalmol Retina

  45. WYKOFF CC, Nittala MG, Zhou B, Fan W, et al
    Intravitreal Aflibercept for Retinal Nonperfusion in Proliferative Diabetic Retinopathy: Outcomes from the Randomized RECOVERY Trial.
    Ophthalmol Retina. 2019 Jul 24. pii: S2468-6530(19)30470.
    PubMed     Text format     Abstract available


    PLoS One

  46. WEI MH, Chen XZ, Zhan XX, Zhang ZX, et al
    The effect of a web-based training for improving primary health care providers' knowledge about diabetes mellitus management in rural China: A pre-post intervention study.
    PLoS One. 2019;14:e0222930.
    PubMed     Text format     Abstract available

  47. DWORZANSKI J, Drop B, Kliszczewska E, Strycharz-Dudziak M, et al
    Prevalence of Epstein-Barr virus, human papillomavirus, cytomegalovirus and herpes simplex virus type 1 in patients with diabetes mellitus type 2 in south-eastern Poland.
    PLoS One. 2019;14:e0222607.
    PubMed     Text format     Abstract available

  48. ZHANG P, Lu Q, Li H, Wang W, et al
    The quality of guidelines for diabetic foot ulcers: A critical appraisal using the AGREE II instrument.
    PLoS One. 2019;14:e0217555.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Diabetes is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: